ストックスクリーナーアプリを入手
11.71
3.26%
0.37
プレマーケット:
11.68
-0.03
-0.26%
前日終値:
$11.34
開ける：
$11.26
24時間の取引高:
1.29M
Relative Volume:
1.10
時価総額：
$1.02B
収益：
-
当期純損益:
$-106.81M
株価収益率:
-3.5359
EPS:
-3.3117
ネットキャッシュフロー:
$-8.40M
1週間 パフォーマンス:
+10.89%
1か月 パフォーマンス:
+23.13%
6か月 パフォーマンス:
+74.00%
1年 パフォーマンス:
-19.90%
1日の値動き範囲:
$11.09
$11.82
1週間の範囲:
$10.00
$12.30
52週間の値動き範囲:
$5.1501
$15.12
Immunome Inc Stock (IMNM) Company Profile
IMNM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
11.71 | 987.09M | 0 | -106.81M | -8.40M | -3.3117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-22 | 開始されました | Goldman | Buy |
| 2025-09-05 | 開始されました | Craig Hallum | Buy |
| 2025-04-02 | 開始されました | Lake Street | Buy |
| 2024-11-08 | 開始されました | Stephens | Overweight |
| 2024-05-31 | 開始されました | Piper Sandler | Overweight |
| 2024-04-30 | 開始されました | JP Morgan | Overweight |
| 2024-04-15 | 開始されました | Guggenheim | Buy |
| 2024-01-29 | 開始されました | Leerink Partners | Outperform |
| 2023-12-19 | 開始されました | Wedbush | Outperform |
| 2021-10-29 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Immunome Inc (IMNM) 最新ニュース
Using fundamentals and technicals on Immunome Inc.Market Risk Analysis & Scalable Portfolio Growth Methods - newser.com
How institutional ownership impacts Immunome Inc. stock2025 Market Trends & Weekly Market Pulse Updates - newser.com
How Immunome Inc. stock reacts to global recession fearsCPI Data & Daily Oversold Bounce Ideas - newser.com
Does Immunome Inc. fit your quant trading model2025 Analyst Calls & Detailed Earnings Play Strategies - newser.com
Immunome, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Market reaction to Immunome Inc.’s recent newsMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Can trapped investors hope for a rebound in Immunome Inc.July 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Key resistance and support levels for Immunome Inc.July 2025 PostEarnings & Technical Pattern Alert System - newser.com
Signal strength of Immunome Inc. stock in tech scannersTrade Entry Report & Verified Swing Trading Watchlist - newser.com
Immunome, Inc. Hits Day Low of $10.02 Amid Price Pressure - Markets Mojo
Immunome, Inc. Hits Day High with 14.13% Surge in Stock Price - Markets Mojo
Immunome, Inc. Hits Day High with Strong 8.09% Intraday Surge - Markets Mojo
How high can Immunome Inc. stock goJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Trend analysis for Immunome Inc. this weekWeekly Stock Report & AI Enhanced Trade Execution Alerts - newser.com
Is Immunome Inc. stock attractive for income investors2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
Goldman Sachs Sees Positive Outlook for Immunome with $26 Price Target - timothysykes.com
Will Immunome's (IMNM) Antibody Partnership Mark a Shift in Its R&D Strategy? - simplywall.st
Immunome Secures Strategic Partnerships, Boosts Market Potential - StocksToTrade
Immunome Stock On the Rise Amid Strategic Collaborations - timothysykes.com
Will Immunome's (IMNM) Antibody Collaboration Refocus Its Pipeline Expansion Strategy? - Yahoo Finance
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Immunome (NASDAQ:IMNM) Stock Price Down 5.9%Here's Why - MarketBeat
Immunome (IMNM) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance
Stocks With Rising Relative Strength: Immunome - Investor's Business Daily
Using R and stats models for Immunome Inc. forecastingForecast Cut & Long-Term Growth Plans - newser.com
Goldman Sachs Group Inc. Decreases Stake in Immunome, Inc. $IMNM - MarketBeat
Immunome (NASDAQ:IMNM) Shares Up 8%What's Next? - MarketBeat
Immunome stock a ‘buy’ on ‘rich pipeline’ of oncology therapeutics: analysts - Proactive financial news
Goldman Sachs Initiates Immunome(IMNM.US) With Buy Rating - 富途牛牛
Ranking Immunome Inc. among high performing stocks via toolsMarket Growth Review & AI Driven Price Forecasts - newser.com
The Goldman Sachs Group Initiates Coverage on Immunome (NASDAQ:IMNM) - MarketBeat
Goldman Sachs initiates coverage on Immunome stock with Buy rating - Investing.com India
Goldman Sachs initiates coverage on Immunome stock with Buy rating By Investing.com - Investing.com South Africa
Is Immunome Inc. still worth holding after the dip2025 Risk Factors & Fast Gain Stock Tips - newser.com
Goldman Sachs Initiates Coverage on Immunome (IMNM) with 'Buy' R - GuruFocus
Immunome Inc (IMNM) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):